NASDAQ:CLDX   Celldex Therapeutics, Inc.
Good time to enter CLDX!
(1) rising trendline
(2) Zacks Rank #2 = buy (short-term for next 1-3 months)
(3) Zacks ABR (5 brokers) = 1.80 (almost strong buy); past brokers' recommendations = 2 holds, 3 buys, 0 strong buy, 0 sell, 0 strong sell
(4) Zacks' Average Target Price = $6.63 (more than double current price of $3.03)
(5) Risk-Reward ratio = 1:1+

Let me know what you think! Peace
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。